Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial

Author:

Aggarwal Rahul1,Bhatt Deepak L.2ORCID,Szarek Michael34,Leiter Lawrence A.5,Cannon Christopher P.1,Lopes Renato D.6,Davies Michael J7,Banks Phillip7,Pitt Bertram8,Steg Ph. Gabriel910

Affiliation:

1. Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School Boston MA USA

2. Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai New York NY USA

3. CPC Clinical Research and University of Colorado Anschutz Medical Campus Aurora CO USA

4. State University of New York Downstate School of Public Health Brooklyn NY USA

5. Li Ka Shing Knowledge Institute, St. Michael's Hospital University of Toronto Toronto ON Canada

6. Duke University School of Medicine Durham NC USA

7. Lexicon Pharmaceuticals, Inc The Woodlands TX USA

8. University of Michigan Ann Arbor MI USA

9. Université Paris‐Cité, INSERMU1148 and AP‐HP Hopital Bichat Paris France

10. French Alliance for Cardiovascular Trials Paris France

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3